Structural flexibility and interactions of PTP1B's S-loop

Interdisciplinary Sciences – Computational Life Sciences

Volumn 1, Issue 3, 2009, Pages 214-219

  Wang, Jing Fang ^a   Gong, Ke ^b   Wei, Dong Qing ^b   Li, Yi Xue ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

essential dynamics analysis; molecular dynamics simulations; protein tyrosine phosphatase 1B; S loop flexibility; type II diabetes and obesity

Indexed keywords

ION; PROTEIN TYROSINE PHOSPHATASE 1B; PTPN1 PROTEIN, HUMAN;

ALGORITHM; ANIMAL; ARTICLE; BIOCHEMISTRY; BIOLOGY; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFORMATION; ENZYME ACTIVE SITE; HUMAN; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; TIME; X RAY CRYSTALLOGRAPHY;

ALGORITHMS; ANIMALS; BIOCHEMISTRY; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; IONS; MOLECULAR CONFORMATION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; SOFTWARE; TIME FACTORS;

EID: 77956628436     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-009-0047-4     Document Type: Article

References (29)

1. Appiah, E. A., Kennedy B. P. 2003. Protein tyrosine phosphatase: The quest for negative regulators of insulin action. Am J Physiol 84, E663-E670.
2. Barford, D., Flint, A. J., Tonks, N. K. 1994. Crystal structure of human protein tyrosine phosphatase 1B. Science 263, 1397-1404.
3. Berendsen, H. J. C., van der Spoel, D., van Drunen R. 1995. GROMACS: a message-passing parallel molecular dynamics implementation. Comp Phys Commun 91, 43-56.
4. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat T. N., Weissig, H., Shindyalov, I. N., Bourne, P. E. 2000. The protein data bank. Nucleic Acids Res 28, 235-242.
5. Cheng, A., Tremblay, M. L. 2004. Insulin receptor PTP: PTP1B. Handb Cell Signal 1, 729-732.
6. Cook, W. S., Unger, R. H. 2002. Protein tyrosine phosphatase 1B: A potential leptin resistance factor of obesity. Dev Cell 2, 385-387.
7. Darden, T., York, D., Pedersen, L. 1993. Particel mesh Ewald: an N-log(N) method for Ewald sums in large systems. J Chem Phys 98, 10089-10092.
8. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Hagen, J. H., Chan, C. C., Ramachandran, C., Gresser, M. J., Tremblay, M. L., Kennedy, B. P. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase 1B gene. Science 283, 1544-1548.
9. Gum, R. J., Gaede, L. L., Koterski, S. L., Heindel, M., Clampit, J. E., Zinker, B. A., Trevillyan, J. M., Ulrich, R. G., Jirousek, M. R., Rondinone, C. M. 2003. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52, 21-28.
10. Hess, B. 2000. Similarities between principal components of protein dynamics and random diffusion. Phys Rev E 62, 8438-8448.
11. Hunter, T. 1995. Protein kinases and phosphatase: the Yin and Yang of protein phosphorylation and signalling. Cell 80, 225-236.
12. Jia, Z., Barford, D., Flint, A. J., Tonks, N. K. 1995. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268, 1754-1758.
13. Johnson, T. O., Ermolieff, J., Jirousek, M. R. 2002. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1, 696-708.
14. Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y. B., Sharpe, A. H., Krongrad, A. S., Shulman, G. I., Neel, B. G., Kahn, B. B. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1Bdeficient mice. Mol Cell Biol 20, 5479-5489.
15. Kolmodin, K., Agvist, J. 2001. The catalytic mechanism of protein tyrosine phosphatases revisited. FEBS Lett 498, 208-213.
16. Liu, G. X., Tan, J. Z., Niu, C. Y., Shen, J. H., Luo, X. M., Shen, X., Chen, K. X., Jiang, H. L. 2006. Molecular dynamics simulations of interaction between proteintyrosine phosphatase 1B and a bidentate inhibitor. Acta Pharm Sin 27, 100-110.
17. Pedersen, A. K., Peters, G. H., Moller, K. B., Iversen, L. F., Kastrup, J. S. 2004. Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. Acta Crystallogr Sect D 60, 1527-1534.
18. Peters, G. H., Frimurer, T. M., Andersen, J. N., Olsen, O. H. 2000. Molecular dynamics simulations of proteintyrosine phosphatase 1B. II. Substrate-enzyme interactions and dyanmics. Biophys J 78, 2191-2200.
19. Stone, R. L., Dixon, J. E. 1994. Protein tyrosine phosphatases. J Biol Chem 269, 31323-31326.
20. Tonks, N. K., Diltz, C. D., Fischer, E. H. 1988. Purification of the major protein tyrosine phosphatases of human placenta. J Biol Chem 263, 6715-6721.
21. van Aalten, D. M. F., Bywater, R., Findlay, J. B., Hendlich, M., Hooft, R. W., Vriend, G. 1996. PRODRG: a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J Comput Aided Mol Des 10, 255-262.
22. van Aalten, D. M. F., De Groot, B. L., Findlay, J. B. C., Berendsen, H. J. C., Amadei, A. 1997. A comparison of techniques for calculating protein essential dyanmics. J Comput Chem 18, 169-181.
23. Wang, J. F., Wei, D. Q., Chen, C., Li, Y. X., Chou, K. C. 2008. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein Pept Lett 15, 27-32.
24. Wang, J. F., Wei, D. Q., Du, H. L., Li, Y. X., Chou, K. C. 2008. Molecular modeling studies on NADP-dependent of Candida tropicallis strain xylose reductase. Open Bioinformatics J 2, 89-96.
25. Wang, J. F., Wei, D. Q., Li, L., Zheng, S. Y., Li, Y. X., Chou, K. C. 2007. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem Biophys Res Commun 355, 513-519.
26. Wang, J. F., Wei, D. Q., Lin, Y., Du, H. L., Li, Y. X., Chou, K. C. 2007. Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP. Biochem Biophys Res Commun 359, 323-329.
27. Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., Fahr, B. J., Zhong, M., Taylor, L., Randall, M., McDowell, R. S., Hansen, S. K. 2004. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 11, 730-737.
28. Wilson, D. P., Wan, Z. K., Xu, W. X., Kirincich, S. J., Follows, B. C., McCarthy, D. J., Foreman, K., Moretto, A., Wu, J. J., Zhu, M., Binnun, E., Zhang, Y. L., Tam, M., Erbe, D. V., Tobin, J., Xu, X., Leung, L., Shilling, A., Tam, S. Y., Mansour, T. S., Lee, J. 2007. Structurebased optimization of protein tyrosine phosphatase 1B inhibitors: From the active site to the second phosphotyrosine binding site. J Med Chem 50, 4681-4698.
29. Zinker, B. A., Rondinone, C. M., Trevillan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., Kroeger, P. E., Reilly, R. M., Koterski, S., Opgenorth, T. J., Ulrich, R. G., Rosby, S., Butler, M., Murray, S. F., McKay, R. A., Bhanot, S., Monia, B. P., Jirousek, M. R. 2002. PTP1B antisense oligo-nucleotide lowers PTP1B protein, normalizesblood glucose, and improves insulin sensitivity in dibetic mice. Proc Natl Acad Sci USA 99, 11357-11362.